I want to thank you all for coming this morning.
To Mr. Meulien, we're all aware of the great work that Genome is doing. You mentioned that by the year 2030, 3% of global GDP will be in the biotech and genome sectors, and Canada has the benefit of the lion's share of all of that.
Could you speak a bit about some of the great success stories we've had in this country in terms of investment, in terms of commercialization, and job creation, and creating the jobs of tomorrow? I just wondered if you could speak a bit about that.